Medtronic (MDT) Cash from Operations Growth (3y) (2017 - 2026)

Medtronic (MDT) Cash from Operations Growth (3y) (2017 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. Growth (3y) (Qtr)
1 Abbott Laboratories 183.00 Bn 175.71 Bn 6.27 Bn 4.78%
2 Stryker 128.69 Bn 125.81 Bn 3.81 Bn 9.30%
3 Medtronic 108.82 Bn 99.60 Bn 6.41 Bn 1.51%
4 Boston Scientific 68.39 Bn 66.93 Bn 3.61 Bn 22.35%
5 Edwards Lifesciences 47.97 Bn 44.30 Bn 1.29 Bn -48.14%
6 GE HealthCare Technologies 28.29 Bn 26.00 Bn 1.98 Bn -14.75%
7 Dexcom 28.21 Bn 27.09 Bn 750.30 Mn 50.11%
8 Smith & Nephew 26.91 Bn 26.33 Bn - -
9 Koninklijke Philips 25.45 Bn 22.32 Bn 2.07 Bn 0.50%
10 Steris 21.55 Bn 21.11 Bn 697.10 Mn 15.83%

Historic Data

Download Data
DateValue
Apr 24, 2026 1.51%
Jan 23, 2026 20.35%
Oct 24, 2025 0.11%
Jul 25, 2025 0.15%
Apr 25, 2025 7.11%
Jan 24, 2025 4.90%
Oct 25, 2024 -18.49%
Jul 26, 2024 -8.62%
Apr 26, 2024 16.75%
Jan 26, 2024 1.64%
Oct 27, 2023 -29.18%
Jul 28, 2023 46.55%
Apr 28, 2023 19.27%
Jan 27, 2023 -13.20%
Oct 28, 2022 -20.96%
Jul 29, 2022 -10.49%
Apr 29, 2022 -0.48%
Jan 28, 2022 2.73%
Oct 29, 2021 15.00%
Jul 30, 2021 -8.78%